[{"path":"index.html","id":"acknowledgements","chapter":"Acknowledgements","heading":"Acknowledgements","text":"Surveillance Congenital Anomalies Nova Scotia (SCAN-NS) like thank Public Health Agency Canada (PHAC) -going support data collection within Nova Scotia. SCA-NS grateful ongoing interest help ofDr. Scott;Dr. Scott;Dr. Skidmore; andDr. Skidmore; andDr. Van den HofDr. Van den HofAs clinical advisors.Special thanks Barry Campbell many staff within Reproductive Care Program Nova Scotia continued support.report prepared :Cora Cole.1John Fahey.2Estevam Teixeira.3","code":""},{"path":"index.html","id":"contact","chapter":"Acknowledgements","heading":"Contact","text":"information, please contact:Cora Cole, Surveillance Congenital Anomalies Nova Scotia, cora.cole@iwk.nshealth.caSuggested citation:Surveillance Congenital Anomalies Nova Scotia, Reproductive Care Program Nova Scotia, Izaak Walton Killam Health Centre (IWK) 2022.","code":""},{"path":"background.html","id":"background","chapter":"Background","heading":"Background","text":"Gaps exist nation’s capacity conduct surveillance congenital anomalies. \\(2002\\), Canadian Congenital Anomalies Surveillance Network (CCASN) establishedTo support development maintenance high quality population-based surveillance systems congenital anomalies provide information improve health Canadian children families.4(http://www.phac-aspc.gc.ca/ccasn-rcsac/index-eng.php)CCASN produced series documents regarding establishment provincial/territorial surveillance systems congenital anomalies5(), coding congenital anomalies6(https://health-infobase.canada.ca/congenital-anomalies/), delineating data elements required minimal enhanced surveillance congenital anomalies7(https://www.phac-aspc.gc.ca/ccasn-rcsac/sac-cas/pdf/cas-eng.pdf).Nova Scotia, data regarding congenital anomalies diagnosed birth birth admission collected since \\(1987\\) Nova Scotia Atlee Perinatal Database (NSAPD) managed Reproductive Care Program Nova Scotia (RCP). NSAPD collects data live born infants stillbirths fetuses delivered \\(\\ge 20\\) weeks gestation, \\(\\ge 500\\) grams, live born co-multiples aforementioned; NSAPD also captures information mothers infants/fetuses mentioned . NSAPD capture data congenital anomaly cases identified admissions occur \\(28\\) days age. NSAPD also capture data pregnancies ending termination.Since \\(1992\\), data regarding congenital anomalies diagnosed antenatally, postnatally time discharge IWK Health Centre, basis autopsy captured Fetal Anomaly Database (FADB) housed Division Maternal Fetal Medicine, IWK Health Centre. IWK obstetrics/paediatric tertiary care centre Maritimes; , FADB captures congenital anomaly cases Nova Scotia resulting live births, still births, terminations. FADB capture congenital anomaly cases diagnosed birth admission, many present data sources within province. FADB also uses -house coding system classify anomalies, practice predates CCASN recommendation use Royal College Paediatrics Child Health codes (adapted International Statistical Classification Diseases Related Health Problems, 10th Revision – ICD-10).","code":""},{"path":"scan-ns-activity-and-report-summary.html","id":"scan-ns-activity-and-report-summary","chapter":"SCAN-NS Activity and Report Summary","heading":"SCAN-NS Activity and Report Summary","text":"first provincial report prevalence congenital anomalies Nova Scotia generated Surveillance Congenital Anomalies Nova Scotia project.first provincial report prevalence congenital anomalies Nova Scotia generated Surveillance Congenital Anomalies Nova Scotia project.International Classification Diseases - \\(10^{th}\\) Edition (ICD-10-CA) adopted IWK Health Centre reporting classification system SCA-NS uses Royal College Paediatrics Child Health adaptation ICD-10 well. anomalies outlined report reflect “sentinel anomalies list” adopted Nova Scotia Congenital Anomaly Advisory Group. anomaly data collected available upon request.International Classification Diseases - \\(10^{th}\\) Edition (ICD-10-CA) adopted IWK Health Centre reporting classification system SCA-NS uses Royal College Paediatrics Child Health adaptation ICD-10 well. anomalies outlined report reflect “sentinel anomalies list” adopted Nova Scotia Congenital Anomaly Advisory Group. anomaly data collected available upon request.Nova Scotia continues participate Canadian Congenital Anomalies Surveillance System (CCASS), administered Maternal Infant Health Section PHAC.Nova Scotia continues participate Canadian Congenital Anomalies Surveillance System (CCASS), administered Maternal Infant Health Section PHAC.numerator data include live births, stillbirths, also fetal losses \\(< 20\\) weeks gestation congenital anomalies. Denominator data include live births stillbirths . including fetal losses numerator, reported rates representative true congenital anomaly rates. Fetal losses ascertained since \\(1992\\).numerator data include live births, stillbirths, also fetal losses \\(< 20\\) weeks gestation congenital anomalies. Denominator data include live births stillbirths . including fetal losses numerator, reported rates representative true congenital anomaly rates. Fetal losses ascertained since \\(1992\\).Data provided report compilation several data Nova Scotia databases.Data provided report compilation several data Nova Scotia databases.Nova Scotia Atlee Perinatal Database (NSAPD).Fetal Anomaly Database (FADB).Canadian Institute Health Information Discharge Abstract Database.Vital Statistics Database; Service Nova Scotia.Medical Services Insurance (MSI) Claims.Data within SCA-NS includes years \\(1992-2021\\) however data additional years available specific inquiries.Data within SCA-NS includes years \\(1992-2021\\) however data additional years available specific inquiries.Congenital anomaly rates remained relatively stable years fluctuations occurring year year basis among specific anomalies.Congenital anomaly rates remained relatively stable years fluctuations occurring year year basis among specific anomalies.","code":""},{"path":"introduction.html","id":"introduction","chapter":"Introduction","heading":"Introduction","text":"purpose SCA-NS improve Congenital Anomaly case ascertainment, cluster detection, local national data comparison reporting capability. Program objectivesProvide baseline data occurrence.Identify populations increased risk.Monitor changes occurrence.Investigate clusters.Refer affected children services.Evaluate prevention programs.Create research opportunities.SCA-NS includes Nova Scotia residents, ascertainment Maritime Provinces cases mother delivered elsewhere. Information cases includes prenatal period one year age including live births, stillbirths terminations pregnancies fetal anomaly detected.","code":""},{"path":"chapter1.html","id":"chapter1","chapter":"1 Methodology","heading":"1 Methodology","text":"","code":""},{"path":"chapter1.html","id":"section11","chapter":"1 Methodology","heading":"1.1 Case Definitions","text":"congenital anomaly abnormality present birth, even diagnosed months years later. congenital anomalies present long time birth, embryonic period (end seventh week gestation) others fetal period (eighth week term). term “anomaly” covers major classes abnormalities development, four major categories follows:Malformation - morphologic defect organ, part organ larger region body resulting intrinsically abnormal developmental process (e.g., spina bifida, cleft lip palate).Malformation - morphologic defect organ, part organ larger region body resulting intrinsically abnormal developmental process (e.g., spina bifida, cleft lip palate).Deformation - abnormal form, shape position part body caused mechanical forces (e.g., extrinsic force intrauterine constraint causing forms clubfoot).Deformation - abnormal form, shape position part body caused mechanical forces (e.g., extrinsic force intrauterine constraint causing forms clubfoot).Disruption - morphologic defect organ, part organ larger region body resulting extrinsic breakdown , interference , originally normal developmental process (e.g., infection rubella teratogen thalidomide).Disruption - morphologic defect organ, part organ larger region body resulting extrinsic breakdown , interference , originally normal developmental process (e.g., infection rubella teratogen thalidomide).Dysplasia - abnormal organization cells tissues morphologic result (e.g., Marfan Syndrome, osteogenesis imperfecta).Dysplasia - abnormal organization cells tissues morphologic result (e.g., Marfan Syndrome, osteogenesis imperfecta).definitions related pregnancy outcomes purposes report follows:Live birth - complete expulsion extraction mother, irrespective duration pregnancy, fetus , expulsion extraction, breathing, beating heart, pulsation umbilical cord definite movement voluntary muscle (Alberta Vital Statistics Annual review, 2000).Live birth - complete expulsion extraction mother, irrespective duration pregnancy, fetus , expulsion extraction, breathing, beating heart, pulsation umbilical cord definite movement voluntary muscle (Alberta Vital Statistics Annual review, 2000).Stillbirth - complete expulsion extraction mother, \\(20\\) weeks pregnancy attaining weight 500 grams , fetus , expulsion extraction, breathing, beating heart, pulsation umbilical cord unmistakable movement voluntary muscle (Alberta Vital Statistics Annual review8).Stillbirth - complete expulsion extraction mother, \\(20\\) weeks pregnancy attaining weight 500 grams , fetus , expulsion extraction, breathing, beating heart, pulsation umbilical cord unmistakable movement voluntary muscle (Alberta Vital Statistics Annual review8).Gestation - completed weeks pregnancy delivery.Gestation - completed weeks pregnancy delivery.Preterm birth (.k.premature) - birth \\(37\\) weeks gestation (\\(< 37\\) weeks).Preterm birth (.k.premature) - birth \\(37\\) weeks gestation (\\(< 37\\) weeks).Termination Pregnancy (ToP) - purposes, includes pregnancy loss 20 weeks gestation (\\(< 20\\) weeks). cases therapeutic terminations congenital anomalies spontaneous abortions intrauterine fetal deaths fetal anomalies also included.Termination Pregnancy (ToP) - purposes, includes pregnancy loss 20 weeks gestation (\\(< 20\\) weeks). cases therapeutic terminations congenital anomalies spontaneous abortions intrauterine fetal deaths fetal anomalies also included.Anomaly definitions based, part, provided International Clearinghouse Birth Defects Surveillance Research (ICBDSR) National Birth Defects Prevention Network (NBDPN).","code":""},{"path":"chapter1.html","id":"section12","chapter":"1 Methodology","heading":"1.2 Case Acertainment","text":"infant can ascertained time first birthday. Multiple ascertainment infant can occur encouraged, frequently improves quality reliability data.several malformations may occur infant, advantageous allow reported groups associated malformations may studied. , however, leads difficulties since final tabulations may reported total malformations (anomaly rates) total number malformed infants (case rates). tables [Appendix A3] report anomaly rates, cases similar case rates (e.g. cleft palate, hypospadias, microcephaly. Whereas limb anomalies, can multiple different limb anomalies infant.SCA-NS obtains information infants congenital anomalies variety independent sources. Acquisition additional reporting agencies always priority since use multiple sources information improves ease also completeness ascertainment well verification diagnostic data.","code":""},{"path":"chapter1.html","id":"section13","chapter":"1 Methodology","heading":"1.3 Quality Control Measures and Data Linkage","text":"Data quality ensured coded linking process manual chart audits unmatched anomaly records. first step data quality control involves linking disparate fetal/infant records databases. Linking based matching several unique variables record.two records “pass”: variable matching process, records considered link therefore report anomalies fetus/infant. allows SCA-NS create record reports anomalies several databases fetus/infant.two records “pass”: variable matching process, records considered link therefore report anomalies fetus/infant. allows SCA-NS create record reports anomalies several databases fetus/infant.records “fail” automated matching process reviewed manually determine information found one data source information entered incorrectly.records “fail” automated matching process reviewed manually determine information found one data source information entered incorrectly.","code":""},{"path":"chapter1.html","id":"section14","chapter":"1 Methodology","heading":"1.4 Confidentiality and Release of Data","text":"","code":""},{"path":"chapter1.html","id":"authority-for-the-collection-use-and-disclosure-of-personal-information","chapter":"1 Methodology","heading":"Authority for the Collection, Use, and Disclosure of Personal Information","text":"Nova Scotia, personal health information protected legislation, policies, professional codes ethics healthcare providers. SCA-NS follow provisions outlined IWK’s Privacy Personal Health Information policy RCP Privacy Policy9 Data Access Research Planning Policy Procedures10","code":""},{"path":"chapter1.html","id":"data-requests","chapter":"1 Methodology","heading":"Data Requests","text":"Data requests reviewed sub-committee Joint Perinatal Epidemiology Research Unit-Population Health Research Unit-RCP Data Access Committee (JDAC). Clinical technical staff participate, representatives stakeholders currently involved providing data, .e. Maternal-Fetal Medicine, BIAP, privacy technical representative, groups Cardiology, database develops. Disclosure research purposes also requires approval recognized Research Ethics Board , approved, Data Use Agreement. SCA-NS consider disclosing individual level data (without personal identifiers) following technical review approval specially-constituted committee.","code":""},{"path":"chapter1.html","id":"limitations-of-data-and-analysis","chapter":"1 Methodology","heading":"Limitations of Data and Analysis","text":"One major limitations surveillance system , information provided allow etiology determined. trends indicate potential problem, separate investigative studies need done. However, appropriate approvals place, possible conduct linkage studies data sources explore potential causes specific birth defects. SCA-NS data collected passively variety sources completeness accuracy data largely dependent reporting coding several different organizations. SCA-NS reviews anomalies entered database regular basis. Detailed studies individual anomalies anomaly groups aid assessment maintenance data quality. intensive review, cases might reassigned, re-coded discarded altogether database. continuing review might explain discrepancies data earlier reports.","code":""},{"path":"chapter1.html","id":"epidemiological-and-statistical-measures","chapter":"1 Methodology","heading":"Epidemiological and Statistical Measures","text":"Unless otherwise stated, formulas used compute prevalence confidence intervals calculated following National Birth Defects Prevention Network (NBDPN) guidelines, chapter 8:\\[\n\\substack{\\text{Prevalence} \\\\ \\\\ \\text{birth}} = 1,000 \\times \\dfrac{\\text{Number cases birth defect area time period}}{\\text{Number live births stillbirths area time period}}\n\\]Pregnancy outcomes included - cases numerator derived pregnancy outcomes collected program may include:\nLive births.\nStillbirths.\nTermination pregnancy (ToP): fetal losses \\(< 20\\) weeks gestation congenital anomalies.\nLive births.Stillbirths.Termination pregnancy (ToP): fetal losses \\(< 20\\) weeks gestation congenital anomalies.denominator, use total number live births stillbirths area time period cases ascertained.","code":""},{"path":"chapter1.html","id":"confidence-intervals","chapter":"1 Methodology","heading":"Confidence intervals","text":"(\\(95\\%\\)) confidence intervals also included rate obtained actually point estimate unknown, true population rate. confidence interval provides information precision estimate. Thus, confidence intervals estimated range values within \\(95\\%\\) probability true population rate fall.\nprevalence based small number cases - small numbers cases (arbitrarily defined \\(< 30\\) cases), use Poisson distribution since birth defects considered rare events. easiest way use Poisson distribution refer table provides upper lower \\(95\\%\\) confidence limits observed number cases. , make use relationship Poisson chi-square distribution functions. \\(X\\) single observation Poisson distribution mean \\(\\mu\\). “exact” \\(95\\%\\) confidence limits \\(\\mu\\) given \\[\n\\small{\n\\left[\\dfrac{qchisq\\left(0.025, 2X\\right)}{2}; \\dfrac{qchisq\\left(0.975, 2(X+1)\\right)}{2}\\right]},\n\\]\\(qchisq()\\) quantile function chi-squared \\(\\left(\\chi^{2}\\right)\\) distribution \\(2X\\), \\(2(X+1)\\) degrees freedom. limits can computed using statistical software taken chi-square table (reproduced \\(5\\) cases).Calculate prevalence\\[\\small{\n1,000 \\times \\dfrac{\\text{Number cases birth defect area time period}}{\\text{Number live births stillbirths area time period}}\n}\\]Look lower upper \\(95\\%\\) confidence limit number cases birth defect . Using new number numerator calculate lower upper \\(95\\%\\) confidence limit prevalence.\\[\n\\scriptsize\n\\begin{aligned}\n\\substack{\\text{Lower } 95\\% \\\\ \\\\ \\text{ CL prevalence}} &= 1,000 \\times \\dfrac{\\text{Lower } 95\\% \\text{ CL cases birth defect area time period}}{\\text{Number live births stillbirths area time period}}\\\\\n\\substack{\\text{Upper } 95\\% \\\\ \\\\ \\text{ CL prevalence}} &= 1,000 \\times \\dfrac{\\text{Upper } 95\\% \\text{ CL cases birth defect area time period}}{\\text{Number live births stillbirths area time period}}\n\\end{aligned}\n\\]Example - Considering birth defect area time period \\(5\\) cases number total births \\(12,500\\) \\[\n\\small\n\\begin{aligned}\n\\text{Prevalence} &= 1,000 \\times \\dfrac{5}{12,500} = 0.4  \\\\\n\\substack{\\text{Lower } 95\\% \\\\ \\\\ \\text{ CL prevalence}} &= 1,000 \\times \\dfrac{1.623}{12,500} = 0.13 \\\\\n\\substack{\\text{Upper } 95\\% \\\\ \\\\\\text{ CL prevalence}} &= 1,000 \\times \\dfrac{11.668}{12,500} = 0.93\n\\end{aligned}\n\\]prevalence based large number cases - large number cases (arbitrarily defined \\(\\ge 30\\) cases), use Normal distribution number cases grows larger, Poisson distribution approximates Normal distribution.\nLet \\(c=\\text{number cases area time period}\\) \\(b=\\text{number live births stillbirths area time period}\\)\nCalculate lower upper confidence limit using following:\nprevalence based large number cases - large number cases (arbitrarily defined \\(\\ge 30\\) cases), use Normal distribution number cases grows larger, Poisson distribution approximates Normal distribution.\nLet \\(c=\\text{number cases area time period}\\) \\(b=\\text{number live births stillbirths area time period}\\)Calculate lower upper confidence limit using following:\\[\n\\small\n\\begin{aligned}\n\\substack{\\text{Lower } 95\\% \\\\ \\\\ \\text{ CL prevalence}} &= 1,000 \\times \\dfrac{\\left( 1- \\dfrac{1}{9c}-\\dfrac{1.96}{3}\\sqrt{\\dfrac{1}{c}} \\right)^{3}}{b}\\times c \\\\\n\\substack{\\text{Upper } 95\\% \\\\ \\\\ \\text{ CL prevalence}} &= 1,000 \\times \\dfrac{\\left( 1- \\dfrac{1}{9\\left(c+1\\right)}+\\dfrac{1.96}{3}\\sqrt{\\dfrac{1}{\\left(c+1\\right)}} \\right)^{3}}{b}\\times \\left(c+1\\right)\n\\end{aligned}\n\\]determine different \\(\\left(1 - \\alpha \\right) \\%\\) confidence limits, replace \\(1.96\\) corresponding value Normal distribution.obtain confidence limits number cases instead prevalence, apply formulae divide \\(b=\\) number live births stillbirths area time period multiply \\(1,000\\).","code":""},{"path":"chapter1.html","id":"trend-analysis","chapter":"1 Methodology","heading":"Trend analysis","text":"appropriate, trend analysis performed. Since response variable interest number cases, fixed upper bound \\(n\\) . Since number cases must take non-negative integer value, distribution place mass range.simplest distribution Poisson. probabilities depend single parameter, mean \\(\\mu\\). Poisson distribution used counts events occur randomly time space, outcomes disjoint periods regions independent. satisfies \\(E\\left(X\\right)=Var\\left(X\\right)=\\mu\\). approaches normality \\(\\mu\\) increases.context prevalence, response count \\(X_{}\\) index \\(t_{}\\) expected value proportional \\(t_{}\\). approach , consider total births index, since value varies time. , sample rate \\(x_{}/t_{}\\), expected value \\(\\mu_{}/t_{}\\). log-linear model expected rate form\\[\n\\begin{aligned}\nlog\\left(\\mu_{}/t_{}\\right) &= \\beta_{0} + \\beta_{1}(Year)  \\\\\nlog\\left(\\mu_{}\\right) - log\\left(t_{}\\right) &= \\beta_{0} + \\beta_{1}(Year)  \\\\\nlog\\left(\\mu_{}\\right) &= \\beta_{0} + \\beta_{1}(Year) + log\\left(t_{}\\right)\n\\end{aligned}\n\\]adjustment term \\(-log\\left(t_{}\\right)\\), log link mean called offset. Another option run model using identity link. model \\[\n\\begin{aligned}\n\\mu_{}/t_{} &= \\beta_{0} + \\beta_{1}(Year)  \\\\\n\\mu_{} &= \\beta_{0}t_{} + \\beta_{1}(Year)t_{}\n\\end{aligned}\n\\]require offset. corresponds ordinary Poisson GLM using identity link intercept exploratory variables \\(t_{}\\), \\((Year)t_{}\\) estimates equal OLS model without intercept.Since working observed rater per 1,000 total births, adjusting yearly count total births equivalent \\(t_{} = \\text{total births}/1,000\\).Sometimes, one can note count data show great variability. Poisson model, expect means variances response various groups. severe limitation Poisson models \\(E \\left(X \\right) = Var \\left(X \\right) = \\mu\\). Hence, fixed mean variance decrease additional predictors enter model. greater variability predicted GLM random component reflects overdispersion. common cause overdispersion subject heterogeneity. Without adjusting overdispersion, use incorrect, artificially small standard errors leading artificially small p-values model coefficients may lead wrong inferences conclusions.can take overdispersion account several different ways. simplest use estimated dispersion factor inflate standard errors. Another way use negative-binomial regression model. case, \\(E\\left(X\\right)= \\mu\\), \\(Var \\left( X \\right) = \\mu + \\gamma \\cdot \\mu^{2}\\). index \\(\\gamma > 0\\) type dispersion parameter. \\(\\gamma \\rightarrow 0\\), \\(Var \\left( X \\right) \\rightarrow \\mu\\) negative binomial distribution converges Poisson.aforementioned model,\\[\n\\mu_{} = \\beta_{0}t_{} + \\beta_{1}(Year)t_{}\n\\]significance tests focus \\(H_{0}: \\beta_{1} =0\\). Wald test uses log-likelihood \\(\\hat{\\beta_{1}}\\), test statistic \\(z=\\hat{\\beta_{1}} / SE(\\hat{\\beta_{1}})\\) square. \\(H_{0}\\), \\(z^{2}\\) asymptotically \\(\\chi^{2}_{1}\\). \\(5\\%\\) level, p-value lower \\(5\\%\\) provide evidences \\(H_{0}\\), meaning \\(5\\%\\) level considered statistically significant.","code":""}]
